Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

astrocytoma, IDH-mutant, grade 2 - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

astrocytoma, IDH-mutant, grade 2

MONDO:0956994

Find Clinical TrialsTrials

Overview

An IDH-mutant anaplastic astrocytoma that is characterized by the presence of well-differentiated fibrillary glial cells diffusely infiltrating the central nervous system.

Clinical Trials3 registered

Diagnosis

Biomarker and diagnostic research for astrocytoma, IDH-mutant, grade 2 has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

3 clinical trials registered. Interventions under study include drug therapy, procedural interventions, and other interventions. Pipeline includes 1 PHASE3, 2 PHASE1. Research is sponsored by a mix of industry and academic institutions.

170 publications have been identified in PubMed for astrocytoma, IDH-mutant, grade 2. Research spans Basic Science / Preclinical (24%), Epidemiology / Natural History (18%), and Review / Meta-Analysis (15%).

Research Type	Count	% of Total
Laboratory research	41

Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 8:41 AM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

Questions for Your Care Team

→Are any of the 3 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

astrocytoma, IDH-mutant, grade 2

Overview

Diagnosis

Research Landscape

Medical References

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications